Fetal and maternalMTHFR C677Tgenotype, maternal folate intake and the risk of nonsyndromic oral clefts
- 11 January 2007
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 143A (3) , 248-257
Abstract
The association between maternal folate intake and risk of nonsyndromic oral clefts has been studied among many populations with conflicting results. The methylenetetrahydrofolate reductase gene (MTHFR)plays a major role in folate metabolism, and several polymorphisms, includingC677T, are common in European populations. Data from a French study (1998–2001) let us investigate the roles of maternal dietary folate intake and theMTHFRpolymorphism and their interaction on the risk of cleft lip with/without cleft palate (CL/P) and cleft palate only (CP). We used both case‐control (164 CL/P, 76 CP, 236 controls; 148, 59, 168 of whom, respectively, had an available genotype) and case‐parent (143 CL/P and 56 CP families) study designs and distinguished the role of the child's genotype and maternally mediated effects on risks. This study observed a beneficial effect of mothers' dietary folate intake on their offspring's risk (odds ratio (OR)≤230 µg/day = ref; for CL/P, OR[230–314 µg/day] = 0.56, 95% confidence interval = 0.3–0.9, OR>314 µg/day = 0.64, 0.4–1.1; for CP, OR[230–314 µg/day] = 1.15, 0.6–2.2, OR>314 µg/day = 0.70, 0.3–1.4). We observed a reduced risk associated with theTTgenotype of the child in the case‐control analysis (ORCC = ref; for CL/P, ORTT = 0.54, 0.3–1.1; for CP, ORTT = 0.33, 0.1–1.0); this genotype, either fetal or maternal, was not statistically significant in the case‐parent analysis. A frequency ofTTgenotype higher in our control group than previously reported in France can partly explain the risk reduction observed in case‐control comparison. Interactions were not statistically significant. Stratified case‐parent analysis showed, however, slight heterogeneity in the role ofTTgenotype according to folate intake. The modest sample size limits this study, which nonetheless provides new estimate of the possible impact of dietary folate intake andMTHFRpolymorphism on oral clefts.Keywords
This publication has 38 references indexed in Scilit:
- Studies of reduced folate carrier 1 (RFC1) A80G and 5,10‐methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defectsAmerican Journal of Medical Genetics Part A, 2005
- Vitamin supplements and the risk for congenital anomalies other than neural tube defectsAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2004
- Does the Interaction between Maternal Folate Intake and the Methylenetetrahydrofolate Reductase Polymorphisms Affect the Risk of Cleft Lip with or without Cleft Palate?American Journal of Epidemiology, 2003
- MTHFR is not a risk factor in the development of isolated nonsyndromic cleft lip and palateAmerican Journal of Medical Genetics, 2002
- Maternal MTHFR genotype contributes to the risk of non-syndromic cleft lip and palateJournal of Medical Genetics, 2002
- Prevention of Neural-Tube Defects with Folic Acid in ChinaNew England Journal of Medicine, 1999
- Role of the C677T polymorphism at theMTHFR gene on risk to nonsyndromic cleft lip with/without cleft palate: Results from a case-control study in BrazilAmerican Journal of Medical Genetics, 1999
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Dietary folate and nonneural midline birth defects: No evidence of an association from a case‐control study in western australiaAmerican Journal of Medical Genetics, 1992